Holen Sie sich die Stockscreener-App
2.38
0.85%
0.02
Vorhandelsmarkt:
2.40
0.02
+0.84%
Schlusskurs vom Vortag:
$2.36
Offen:
$2.36
24-Stunden-Volumen:
29,788
Relative Volume:
0.01
Marktkapitalisierung:
$13.66M
Einnahmen:
$34.75M
Nettoeinkommen (Verlust:
$-24.76M
KGV:
-0.1983
EPS:
-12
Netto-Cashflow:
$-50.91M
1W Leistung:
+3.93%
1M Leistung:
-25.63%
6M Leistung:
-87.63%
1J Leistung:
-95.26%
1-Tages-Spanne:
$2.33
$2.42
1-Wochen-Bereich:
$2.22
$2.4425
52-Wochen-Spanne:
$2.15
$88.75
Allurion Technologies Inc Stock (ALUR) Company Profile
Firmenname
Allurion Technologies Inc
Sektor
Branche
Telefon
508-647-4000
Adresse
11 HURON DR STE 200, NATICK
Vergleichen Sie ALUR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALUR
Allurion Technologies Inc
|
2.38 | 13.66M | 34.75M | -24.76M | -50.91M | -12.00 |
|
ABT
Abbott Laboratories
|
130.50 | 228.46B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
102.74 | 140.59B | 17.55B | 2.03B | 2.37B | 1.37 |
|
SYK
Stryker Corp
|
370.92 | 132.87B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
84.60 | 106.93B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
76.28 | 41.35B | 5.54B | 4.18B | 259.90M | 7.00 |
Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-14 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2024-10-02 | Eingeleitet | TD Cowen | Buy |
| 2024-09-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-02-09 | Eingeleitet | Jefferies | Buy |
Allurion Technologies Inc Aktie (ALUR) Neueste Nachrichten
Allurion Technologies Inc. (NYSE:ALUR) Sees Large Drop in Short Interest - Defense World
Allurion Technologies, Inc. (ALUR) Reports Q4 Loss, Lags Revenue Estimates - MSN
Long Term Trading Analysis for (ALUR) - news.stocktradersdaily.com
4 Medical Product Stocks to Buy From a Challenging Industry - Zacks Investment Research
Allurion announces study on obesity treatment enhancement - MSN
Allurion Technologies gains approval for warrant repricing - Investing.com
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session - Benzinga
(ALUR) Investment Report - news.stocktradersdaily.com
Allurion reschedules special stockholders meeting to April 10 By Investing.com - Investing.com India
Allurion reschedules special stockholders meeting to April 10 - Investing.com
Allurion Gives Shareholders More Time: Key Meeting Rescheduled to April 10 - Stock Titan
Allurion Announces Postponement of Special Meeting of Stockholders - Bluefield Daily Telegraph
Allurion Technologies CEO Gaur Shantanu acquires $26,800 in stock By Investing.com - Investing.com Canada
Allurion Technologies CEO Gaur Shantanu acquires $26,800 in stock - Investing.com India
Allurion Technologies CEO Acquires 8,000 Shares - TradingView
Q1 EPS Forecast for Allurion Technologies Cut by Analyst - Defense World
Allurion Technologies’ Earnings Call: Growth Amid Challenges - TipRanks
3 Best Stocks to Buy Now, 3/28/2025, According to Top Analysts - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Allurion Technologies (ALUR), Perspective Therapeutics (CATX) and Nkarta (NKTX) - The Globe and Mail
Chardan holds Allurion stock at Neutral with a $2.50 target By Investing.com - Investing.com South Africa
Chardan holds Allurion stock at Neutral with a $2.50 target - Investing.com
Allurion Technologies Inc (ALUR) Q4 2024 Earnings Call Highlights: Strategic Restructuring and ... By GuruFocus - Investing.com Canada
Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - BioSpace
TD Cowen Cuts Allurion Technologies' Price Target to $6 From $16, Buy Rating Maintained - MarketScreener
Earnings call transcript: Allurion Technologies’ Q4 2024 shows revenue drop, strategic shifts By Investing.com - Investing.com South Africa
Earnings call transcript: Allurion Technologies’ Q4 2024 shows revenue drop, strategic shifts - Investing.com
Allurion Technologies Inc reports results for the quarter ended December 31Earnings Summary - TradingView
ALLURION TECHNOLOGIES Earnings Results: $ALUR Reports Quarterly Earnings - Nasdaq
Earnings Scheduled For March 26, 2025 - Benzinga
What To Expect From Allurion Technologies Inc (ALUR) Q4 2024 Earnings - Yahoo Finance
Allurion Technologies’ (ALUR) “Buy” Rating Reiterated at Roth Mkm - Defense World
Allurion surges on weight loss data from gastric balloon, GLP-1 combo treatment - MSN
Gold Down Over 1%; Micron Technology Shares Fall After Q2 Earnings - Benzinga
Allurion Stock Soars on Promising GLP-1 Combo Results - Wall Street Pit
Promising Potential of Allurion Technologies’ Innovative Approach Supports Buy Rating - TipRanks
Pre-market Movers: IBO, ALUR, GCTK, TELA... - RTTNews
Why Ouster Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
US Stocks Likely To Open Lower, But 'Economic Conditions Don't Signal A Downturn,' Say Analysts As They Expect 'Resilient Earnings' To Lift EquitiesAllurion Technologies (NYSE:ALUR), Accenture (NYSE:ACN) - Benzinga
Allurion reports weight loss and muscle gain with new therapy By Investing.com - Investing.com South Africa
Allurion Technologies Reports Positive Ballon Combination Study Results; Shares Jump - MarketScreener
Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence - BioSpace
12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session - Benzinga
Allurion reports weight loss and muscle gain with new therapy - Investing.com India
Revolutionary Weight Loss Results: Allurion Balloon Plus Low-Dose GLP-1 Shows 20% Weight Loss, Preserves Muscle - StockTitan
ALLURION TECHNOLOGIES Earnings Preview: Recent $ALUR Insider Trading, Hedge Fund Activity, and More - Nasdaq
Allurion’s Next-Generation Weight Loss Device Earns New Patents - Medical Product Outsourcing
Allurion Technologies (ALUR) Projected to Post Quarterly Earnings on Thursday - Defense World
Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025 - The Joplin Globe
Finanzdaten der Allurion Technologies Inc-Aktie (ALUR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.01%
0.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):